AXGN
AxoGen, Inc.
NASDAQ · USHealthcareMedical - Devices
$39.48-0.93%
Price as of Jul 20, 2026
AXGN capital
AxoGen, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.08x
- Net debt / equity
- -0.25x
- Debt / assets
- 0.07x
- Debt / EBITDA
- -2.51x
- Net debt / EBITDA
- 7.53x
Liquidity & coverage
- Current ratio
- 7.10x
- Quick ratio
- 5.33x
- Cash ratio
- 3.18x
- Interest coverage
- -0.62x
- EBITDA / interest
- -0.56x
- Working capital
- $158.7M
Cash & dividend
- FCF / debt
- 0.43x
- Cash flow / debt
- 0.75x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- +1566.7%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.